CommercialPrior AuthLow impact
Drug Policy Criteria Change
Arkansas Blue Cross Blue Shield·AR · Cardiology, Endocrinology, Family Medicine +1 more·Pharmacy
Effective date
Feb 25, 2026
We identified it
Jun 19, 2026
Summary
Arkansas Blue Cross updated the indication question for Nexlizet drug coverage to match the updated labeling of Nexletol and Nexlizet medications. This affects prior authorization criteria for these cholesterol medications on Standard and Metallic formulary tiers.
Action Required
Before February 25, 2026: Providers prescribing Nexlizet should review updated indication criteria with Arkansas Blue Cross to ensure proper prior authorization approval. Update any internal formulary references to reflect the new indication questions for Standard and Metallic plan members.